On 18 December 2023, the Therapeutic Goods Administration reminded all health practitioners that use of the previously popular terms ‘Anti Wrinkle Injections’ and ‘Dermal Fillers’ was not permitted in advertising.
TGA’s reasoning is that ‘Anti-Wrinkle Injections’ and ‘Dermal Fillers’ are classed as ‘prescription medicines’, and accordingly it is illegal to influence consumers about the use or supply of prescription medicines through advertising.
TGA added that even though the brand names of those products are not being advertised, the generic terms ‘Anti-Wrinkle Injections’ and ‘Dermal Fillers’ still “draw the audience’s mind” to prescription-only products.
Currently, all practitioners performing non-surgical cosmetic procedures are still awaiting TGA’s further guidelines as to what descriptions will be allowed after TGA indicated it would provide further guidelines by late January 2024.
